...
首页> 外文期刊>Clinical nuclear medicine >Hodgkin lymphoma post-transplant lymphoproliferative disorder following pediatric renal transplant: serial imaging with F-18 FDG PET/CT.
【24h】

Hodgkin lymphoma post-transplant lymphoproliferative disorder following pediatric renal transplant: serial imaging with F-18 FDG PET/CT.

机译:小儿肾移植后的霍奇金淋巴瘤移植后淋巴增生性疾病:用F-18 FDG PET / CT进行连续成像。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Post-transplant lymphoproliferative disorder (PTLD) occurs in 1.2% of pediatric renal transplant patients, and is frequently Epstein-Barr Virus mediated. Hodgkin Lymphoma PTLD is the rarest of the 4 types of PTLDs recognized by the World Health Organization, with an incidence of <4% of all PTLD patients. It has a distinct clinical course and treatment from all other types of PTLD. This is a case of a 16-year-old girl who had a renal transplant in 2000 due to Moya Moya disease. Her first F-18 FDG PET/CT done in 2006 showed mildly FDG-avid mediastinal adenopathy (histologically nonspecific reactive nodes), however in 2009, after presenting with fevers, a repeat PET/CT showed extensive intensely FDG-avid disease. Biopsy of a supraclavicular node identified Hodgkin Lymphoma PTLD. The patient was treated with chemotherapy and reimaged, showing excellent response to therapy. In contrast, classic PTLD is treated by withdrawal of immunosuppression and administration of Rituximab. F-18 FDG PET/CT is known to be very useful in the staging and monitoring of response to therapy in the setting of classic PTLD. In this case, serial F-18 FDG PET/CT scans proved very useful in the evaluation and follow-up of the rare and distinct Hodgkin Lymphoma PTLD subtype.
机译:移植后的淋巴增生性疾病(PTLD)发生在1.2%的小儿肾脏移植患者中,并且通常是由爱泼斯坦-巴尔病毒介导的。霍奇金淋巴瘤PTLD是世界卫生组织认可的4种类型的PTLD中最稀少的一种,其发病率<所有PTLD患者的4%。与所有其他类型的PTLD相比,它具有独特的临床过程和治疗方法。这是一名16岁女孩的案例,该女孩因莫亚莫亚病于2000年进行了肾脏移植。她于2006年完成的第一架F-18 FDG PET / CT表现为轻度FDG-avid纵隔腺病(组织学上非特异性反应性淋巴结),但是在2009年发烧后,重复的PET / CT表现为广泛的严重FDG-avid疾病。锁骨上淋巴结活检发现霍奇金淋巴瘤PTLD。该患者接受化学疗法治疗并重新成像,显示出对治疗的出色反应。相反,经典的PTLD是通过撤消免疫抑制和给予利妥昔单抗来治疗的。 F-18 FDG PET / CT在经典PTLD的背景下,对治疗反应的分期和监测非常有用。在这种情况下,连续F-18 FDG PET / CT扫描被证明对罕见和独特的霍奇金淋巴瘤PTLD亚型的评估和随访非常有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号